Arena session – Novo Nordisk A/S
Coming soon… Novo Nordisk A/S Thursday, 18 September 2025 17:00 – 17:30 CEST Arena
Coming soon… Novo Nordisk A/S Thursday, 18 September 2025 17:00 – 17:30 CEST Arena
Chair: Steven E. Kahn (USA) 17:45 – 17:50 Welcome and introduction Steven E. Kahn (USA) 17:50 – 18:05 Stepping up holistic care: incretin-based and novel
17:45 – 17:53 Welcome and introduction TBC 17:53 – 18:08 The interplay of COVID-19 and cardiometabolic diseases TBC 18:08 – 18:23 The importance of staying
17:45 – 17:55 Introduction. The Growing Burden of MASLD/MASH: A Call to Action TBC 17:55 – 18:10 Changing the MASH Paradigm with THR-β Agonists and
Chair: Alice Cheng (CAN) 17:45 – 17:50 Establishing a connection: addressing the relationship between cardio, renal and metabolic conditions Alice Cheng (CAN) 17:50 – 18:05
Coming soon… Roche Monday, 15 September 2025 12:30 – 13:00 CEST Spotlight Stage
Chair: Ohad Cohen (CHE) Wednesday, 17 September 2025 16:00 – 16:30 CEST Arena
Coming soon… SANOFI Wednesday, 17 September 2025 16:00 – 16:30 CEST Spotlight Stage
Coming soon… Abbott Friday, 19 September 2025 11:00 – 11:30 CEST Spotlight Stage
Chair: Jonathan Rachman (GBR) 17:00 – 17:30 Disease modification in type 2 diabetes. What have we learnt? Stefano Del Prato (ITA) Jonathan Rachman (GBR) Thursday,
